Fleury S A : Annual Sustainability Report 2022

The year 2021 was full of challenges and transformations for Fleury Group, resulting in the sustainable growth of the business, making us increasingly prominent in Brazilians' health. In a period still affected by the Covid-19 pandemic, resilience was a crucial pillar for us to deliver, focused on the customer, and to achieve positive results on different fronts.

During the year, we reviewed our strategic planning, formally establishing the three growth avenues for the coming years. We thus combined our tangible and digital offerings and integrated the Diagnostic Medicine, Health Platform (Saúde iD) and New Links in the health chain, offering a broad portfolio of services in varied specialties such as medicine infusion, reproductive medicine, orthopedics, ophthalmology and outpatient surgical center.

Diagnostic medicine will continue to be our main focus, but we have created other avenues to offer increasingly integrated care to our clients, with the quality that Fleury

Group is known for, expanding the number of lives served.

Under new executive management at the head of all three growth avenues, we achieved the highest revenue, highest EBITDA and highest net income in our history. The record performance was a conjunction of the business' organic growth, which raised gross revenue by 24%, plus the six acquisitions announced, three in Diagnostic Medicine and three in Novos Elos, respectively in the infusions, orthopedics and ophthalmology segments.

Our acquisitions and strategic investments towards building the end-to-end healthcare ecosystem have further strengthened and expanded our business scale, ensuring the conditions for long-term sustainable growth focused on adding value to the customer's healthcare journey.

The long-term view also permeates the group's cultural evolution towards its ESG performance. In 2021, we further brought the

topic to the center of our strategy, with the ESG targets starting to impact the executive compensation and the creation of an ESG Committee, evidencing the commitment of everyone to the subject. Additionally, we carried out the first issue of ESG deben- tures: an SLB (Sustainability Linked Bonds) in the amount of R$ 1 billion.

The Company's inclusion for the second year in B3's Dow Jones Sustainability Index (DJSI) and in B3's Carbon Efficient Index (ICO2), as well as its permanence in Corporate Sustainability Index (ISE) port- folio, also from B3, for the ninth consecutive year, crown the recognition of our ESG strategy, which remains linked to the voluntary commitments made with the United Nations (UN) Global Compact..

Finally, 2021 was also the year in which we set a new record, directly related to our innovation capacity. There were 430 implementations of new services, products and methodologies, a 35% growth when compared to the previous year. Gains from

these projects are vital for the positioning of leadership and quality in our business, besides providing a cost reduction of R$ 127 million in the period.

We would like to thank the work of all the teams, as well as the trust of our customers and partners throughout the year. For 2022, we will continue with a broad discipline in the execution of the established planning, seeking a robust performance by offering services that are a reference in health in the country.

Board of Directors

and Executive Board

3

Sustainability Report · 2021

How to read the report

The references used throughout the document unfold in different ways of reading the Report. Therefore, in addition to the linear reading, it is possible to browse through the contents according to the reporting guidelines adopted:

CAPITALS: based on the Integrated Reporting, we pointed out which capitals are addressed in each chapter. At the end of the Report, in the Capitals Map (page 120), we present the pages in which each capital is addressed.

Capitals:

SUSTAINABLE DEVELOPMENT GOALS

GRI and SASB INDICATORS: at the beginning of each subchapter, we present the disclosures that will be reported, by means of the acronyms "GRI-" and "SASB-". The full list of disclosures can be found on page 108.

GLOBAL COMPACT: to demonstrate our evolution in the Global Compact princi- ples, we report in the GRI Content Index the correlation between the guideline indicators for each principles.

NaturalIntellectual

Social and

RelationshipFinancial

ManufacturedHuman

(SDGs): taking into consideration our commitment to the SDGs, we point out the connection of each chapter's content with the goals on the SDG Map (page 119).

TASK FORCE ON CLIMATE-RELATED

FINANCIAL DISCLOSURES (TCFD): in the TCFD Index (page 116), we present the answers or the page where the recommendations are reported throughout the document.

5

Sustainability Report · 2021